Myeloid Therapeutics Securities Corp is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics for myeloid-related diseases.
With a focus on cutting-edge research and technology, the company aims to address unmet medical needs and improve patient outcomes in the field of myeloid disorders.
Generated from their business information